News Conference News ESOC 2025 Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors Todd Neale June 02, 2025
News Conference News ESOC 2025 Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke Todd Neale May 23, 2025
News Conference News CRT 2025 Need for Rethink of Discharge Medications After LAA Closure? EMERGE L.A. McKeown March 12, 2025
News Conference News ESOC 2024 Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yet Todd Neale May 16, 2024
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News EuroPCR 2022 Registry Data Hint at MACE Benefit With Renal Denervation Michael O'Riordan May 17, 2022
News Conference News ESC 2021 Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD Michael O'Riordan August 29, 2021
News Conference News ESC 2021 ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients Todd Neale August 29, 2021
News Conference News ISC 2021 Ischemic Stroke, TIA Risk in COVID-19 Lower Than Previously Seen Todd Neale March 22, 2021
News Conference News TCT 2020 Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results Michael O'Riordan October 16, 2020
News Conference News CRT 2020 Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves Michael O'Riordan February 27, 2020
News Conference News AHA 2019 Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial Shelley Wood November 18, 2019
News Conference News EuroPCR 2019 New Clarity on Patients at High Risk for Bleeding After PCI Michael O'Riordan May 28, 2019
News Conference News ESC Heart Failure 2019 Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis Shelley Wood May 26, 2019
News Conference News WCC 2018 Man’s Best Friend, Especially After an MI or Stroke Todd Neale December 11, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News ESC 2018 ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients L.A. McKeown August 31, 2018
News Conference News ISC 2018 COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke Todd Neale January 25, 2018